Sirolimus Reduces Post-Transplant HIV Levels
Lower post-transplant HIV DNA levels associated with sirolimus use.
Lower post-transplant HIV DNA levels associated with sirolimus use.
Mortality rate is high, especially among patients with HIV/AIDS.
HIV-1 was found in podocytes or tubular cells of renal allografts in recipients who did not have detectable plasma levels of the virus.
HIV is strongest predictor of erectile dysfunction for young and middle-aged men.
Evidence suggests that HIV-positive patients have the same favorable outcomes in terms of patient and allograft survival as non-HIV positive kidney transplant recipients.
HIV is no longer a contraindication to transplantation, contends Dorry Segev, MD, PhD.
If Congress reversed its ban on allowing people with HIV to be organ donors after their death, approximately 500 HIV-positive patients with kidney or liver failure each year could get transplants within months instead of years, according to researchers.
The trend could be a response to cases of transplant-related HIV transmission in November 2007.
Clinicians should consider the possibility that HIV patients have both renal and cardiac disease.
HIV infection has an additive effect on microalbuminuria risk in patients with type 2 diabetes.